Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis
Int J Rheum Dis
.
2023 Jan;26(1):172-174.
doi: 10.1111/1756-185X.14460.
Epub 2022 Oct 14.
Authors
Allen Pai
1
2
,
Yung-Heng Lee
3
4
5
,
Meng-Yu Ko
6
7
,
Po-Ku Chen
8
9
Affiliations
1
New Drug, New Medical Device, New Medical Technology Clinical Trial Management Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
2
Department of Public Health, National Taiwan University, Taipei, Taiwan.
3
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
4
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
5
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
6
Division of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
7
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
8
Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung, Taiwan.
9
Department of Integrated Chinese and Western Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
PMID:
36239091
DOI:
10.1111/1756-185X.14460
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Humans
Inflammation
Intestines
Leukocyte L1 Antigen Complex*
Spondylarthritis* / diagnosis
Substances
Leukocyte L1 Antigen Complex
Biomarkers